S&P Futures
3,832.50 +7.00 (+0.18%) Dow Futures
30,985.00 +52.00 (+0.17%) Nasdaq Futures
11,700.50 +26.25 (+0.22%) Russell 2000 Futures
1,741.50 +3.20 (+0.18%) Crude Oil
111.16 -0.60 (-0.54%) Gold
1,822.40 +1.20 (+0.07%)
TransMedics Group, Inc. (TMDX)
After hours:
- Motley Fool
Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High
Suppose you invest in all three of these healthcare companies, and two of them go belly up. Here are our selections for biotech stocks that can run up 1,000% by 2027. George Budwell (Intellia Therapeutics): If you're on the hunt for a stock that can produce life-changing gains over the next five years, the beaten-down biotech industry is definitely a good place to start your search.
- Simply Wall St.
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- PR Newswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on June 1, 2022, TransMedics granted non-qualified stock options to purchase an aggregate of 35,000 shares of its common stock to three employees as a material inducement for each employee's entry into employment with TransMedics. The options were approved by the Compensation Committee o
